Human proislet peptide(Boston Therapeutics)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman proislet peptide(Boston Therapeutics)
Drug Alias NameProisletide acetate
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionCell differentiation stimulants
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBoston Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesBoston Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A